A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Droxidopa Impurity 12 | Droxidopa Impurity 12. Uses: For analytical and research use. Alternative Names: 2,3,8,9-tetrahydroxy-5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene-5-carboxylic acid. Molecular formula: C17H15NO6. Mole weight: 329.30. Catalog: APB05134. |  |
| Droxidopa Impurity 14 | Droxidopa Impurity 14. Uses: For analytical and research use. Alternative Names: 2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid. CAS No. 3916-18-5. Molecular formula: C9H11NO5. Mole weight: 213.19. Catalog: APB3916185. | |
| Droxidopa impurity 2 | Droxidopa impurity 2. Uses: For analytical and research use. Molecular formula: C17H15ClN2O7. Mole weight: 394.76. Catalog: APB11654. | |
| Droxidopa Impurity 2 | Droxidopa Impurity 2. Uses: For analytical and research use. Alternative Names: 2-(3,4-dihydroxyphenyl)acetaldehyde. CAS No. 5707-55-1. Molecular formula: C8H8O3. Mole weight: 152.15. Catalog: APB5707551. | |
| Droxidopa impurity 3 | Droxidopa impurity 3. Uses: For analytical and research use. Molecular formula: C16H14N2O5. Mole weight: 314.3. Catalog: APB11655. | |
| Droxidopa Impurity 3 | Droxidopa Impurity 3. Uses: For analytical and research use. Alternative Names: (2R,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid. CAS No. 51829-98-2. Molecular formula: C9H11NO5. Mole weight: 213.19. Catalog: APB51829982. | |
| Droxidopa Impurity 4 | Droxidopa Impurity 4. Uses: For analytical and research use. Alternative Names: (2S,3R)-2-(((benzyloxy)carbonyl)amino)-3-(3,4-bis(benzyloxy)phenyl)-3-hydroxypropanoic acid. CAS No. 55382-14-4. Molecular formula: C31H29NO7. Mole weight: 527.56. Catalog: APB55382144. | |
| Droxidopa Impurity 5 | Droxidopa Impurity 5. Uses: For analytical and research use. Alternative Names: 51829-99-3 (free base); (2R,3S)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid hydrochloride. Molecular formula: C9H11NO5·HCl. Mole weight: 249.65. Catalog: APB05136. | |
| Droxidopa Impurity 6 | Droxidopa Impurity 6. Uses: For analytical and research use. Alternative Names: 5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene-2,3,8,9-tetraol. CAS No. 90044-46-5. Molecular formula: C16H15NO4. Mole weight: 285.29. Catalog: APB90044465. | |
| Droxidopa Impurity 7 | Droxidopa Impurity 7. Uses: For analytical and research use. Alternative Names: (2S,3R)-2-amino-3-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoic acid. CAS No. 28865-97-6. Molecular formula: C10H13NO5. Mole weight: 227.21. Catalog: APB28865976. | |
| Droxidopa Impurity 8 | Droxidopa Impurity 8. Uses: For analytical and research use. Alternative Names: (2S,3S)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid. CAS No. 34047-62-6. Molecular formula: C9H11NO5. Mole weight: 213.19. Catalog: APB34047626. | |
| Droxidopa Impurity 9 | Droxidopa Impurity 9. Uses: For analytical and research use. Alternative Names: (2S,3R)-2-amino-3-(3-(benzoyloxy)-4-hydroxyphenyl)-3-hydroxypropanoic acid. Molecular formula: C16H15NO6. Mole weight: 317.29. Catalog: APB05135. | |
| Droxinostat | Droxinostat (NS 41080) is a histone deacetylase (HDAC) inhibitor. Droxinostat selectively inhibits HDAC3, HDAC6, and HDAC8 with IC50 values of 16.9 μM, 2.47 μM, and 1.46 μM, respectively. Droxinostat can be used for the research of hepatocellular carcinoma (HCC)[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: NS 41080. CAS No. 99873-43-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13267. |  |
| Droxinostat | Droxinostat. Group: Biochemicals. Alternative Names: 4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide; NS 41080. Grades: Highly Purified. CAS No. 99873-43-5. Pack Sizes: 10mg. Molecular Formula: C11H14ClNO3, Molecular Weight: 243.69. US Biological Life Sciences. |  Worldwide |
| Drozitumab | Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody. CAS No. 912628-39-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99286. | |
| DRP1 Antibody [H2B5] | DLP1,DNM1L,DRP1. Group: Antibodies. Alternative Names: DLP1,DNM1L,DRP1. Pack Sizes: 20ul. Product ID: F0328. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. |  United States; Europe |
| DRP1i27 | DRP1i27 is a potent inhibitor of human Drp1 (dynamin-related protein 1). DRP1i27 binds to the GTPase site of Drp1, with hydrogen bonds to Gln34 and Asp218. DRP1i27 targets Drp1-mediated mitochondrial fission in cell line models and protects against simulated ischemia-reperfusion injury[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1453028-33-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-152086. | |
| Drp1-IN-1 | Drp1-IN-1 is a dynamin-1-like protein (Drp1) inhibitor with an IC50 of 0.91 μM. Drp1 mediates the fission of the outer mitochondrial membrane. Drp1-IN-1 can be used to study diseases associated with mitochondrial dysfunction[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2247733-08-8. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-125222. | |
| Drp1 peptide inhibitor P110 | Drp1 peptide inhibitor P110 (Compound P110) is a selective Drp1 peptide inhibitor with neuroprotective properties. Drp1 peptide inhibitor P110 can inhibit the activation of Drp1, prevent MPTP-induced Drp1 mitochondrial translocation, and alleviate MPTP-induced dopaminergic neuron loss, dopaminergic nerve terminal damage, and behavioral deficits, and can be used in the study of Alzheimer's disease. Additionally, Drp1 peptide inhibitor P110 can reduce mitochondrial damage and organ injury in animal models of Huntington's disease, cerebral ischemic injury, and myocardial infarction[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2770267-63-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P6437. | |
| DRP-PBN1 | PBN1 is an antimicrobial peptide found in Phyllomedusa bicolor (South American two-colored leaf frog), and has antibacterial activity. Alternative Names: PBN1; H-Phe-Leu-Ser-Leu-Ile-Pro-His-Ile-Val-Ser-Gly-Val-Ala-Ala-Leu-Ala-Lys-His-Leu-Gly-OH; Antimicrobial peptide, Dermaseptin-like peptide PBN1. Grades: ≥96%. Molecular formula: C97H159N25O23. Mole weight: 2043.48. |  |
| Drug-Fragment Library | Quantity: 1159 drug fragments?a must-have tool for FBDD; - Physiochemical properties: 53% of fragments are Ro3 compliant?and all fragments matching with approved drugs or clinical compounds will have the best drug potential; - Quality guaranteed: NMR and HPLC/LCMS validated to ensure high purity and quality; - Applicable to various detection methods: suitable for SPR, NMR, and X-ray crystallization screening. Uses: Scientific use. Product Category: L8800. Categories: Drug-Fragment Libraries. |  |
| Drug-induced Liver Injury (DILI) Compound Library | A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening?- Include anti-cancer drugs, antibiotics, antituberculotic agents, antiretrovirals, antiepileptic agents, and cardiac medications, etc. ?- Diversified in toxicities: Steatosis, Mitochondrial toxicity, cholestasis, drug allergy (hypersensitivity), etc. ; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L5510. Categories: Drug-induced Liver Injury (DILI) Compounds Libraries. | |
| Drug Metabolite/Impurity Library | A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); - Structurally diverse, medicinally active, and cell permeable; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - NMR and HPLC/LCMS validated to ensure high purity and quality. Uses: Scientific use. Product Category: L5800. Categories: Drug Metabolite/Impurity Libraries. | |
| Drug Repurposing Compound Library | A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); - An effective tool for discovering new with old drugs, cell induction, and new drug target screening; - All approved drugs collected in this library are approved by Food and Drug Administration (FDA), the European Medicine Agency (EMA), or National Medical Products Administration (NMPA), or included in the US Pharmacopeia (USP) Dictionary, the British Pharmacopoeia (BP), the European Pharmacopoeia (EP), the Japanese Pharmacopoeia (JP), or Chinese Pharmacopoeia (CP) Dictionary; - Covers various research areas, such as cancer, cardiovascular disease, immunology, respiratory system, etc. - Covers various targets, such as 5-HT Receptor, Sodium Channel, p38 MAPK, PI3K, MEK, etc. - Detailed compound information with structure, target, activity, and brief introduction; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L9200. Categories: Drug Repurposing Compounds Libraries. | |
| Drum Dried Purple Sweet Potato Powder | Drum Dried Purple Sweet Potato Powder. |  CA, FL & NJ |
| Drupanin | Drupanin is an orally active and selective AKR1C3 enzyme inhibitor and an RXRα agonist with an EC50 value of 4.8 μM, which is found in green propolis. Drupanin also activates PPARγ moderately. Drupanin induces adipogenesis and elevates aP2 mRNA levels in 3T3-L1 fibroblasts Drupanin has the potential for the research of breast and prostate cancers[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 53755-58-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N10361. | |
| Dryfast Foam-Type 1 | Dryfast foams are suited for outdoor use where moisture and precipitation like rain is prevalent, such as in patio furniture, including under Phifertex material, or in marine cushioning on personal watercraft. The large, open cells provide a degree of airflow not present in other foams, allowing it to dry quickly, even after complete saturation. |  |
| Dryfast Foam-Type 2 | Dryfast foams are suited for outdoor use where moisture and precipitation are prevalent, such as in patio furniture, including under Phifertex material, or in marine cushioning on personal watercraft. The large, open cells provide a degree of airflow not present in other foams, allowing it to dry quickly, even after complete saturation. | |
| Dryocrassin ABBA | Dryocrassin ABBA showed anti-tumor promoting activity and anti-bacterial activity. Alternative Names: 2,5-Cyclohexadien-1-one, 2,2'-(methylenebis((2,4,6-trihydroxy-5-(1-oxobutyl)-3,1-phenylene)methylene)bis(6-acetyl-3,5-dihydroxy-. Grades: >98%. CAS No. 12777-70-7. Molecular formula: C43H48O16. Mole weight: 820.8. | |
| DRY VITAMIN A PALMITATE ,TYPE250CWS | DRY VITAMIN A PALMITATE ,TYPE250CWS. Product ID: ACMA00005829. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| DS02312223 | DS02312223 (D223) is a molecular glue that promotes the binding of RAS to PI3Kα, with a Kd of 0.76 μM for p110α. DS02312223 increases the binding affinity between GTP-bound KRAS (KRAS-GMPPNP) and p110α by nearly three orders of magnitude (KD = 0.017 μM). DS02312223 stimulates the translocation of GLUT4 to the plasma membrane. DS02312223 promotes glucose uptake in the absence of insulin. DS02312223 can be used in diabetes research[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: D223. CAS No. 2253733-45-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-W1126235. | |
| DS08210767 | DS08210767 is a highly potent, orally bioavailable PTHR1 antagonist with IC50 of 90 nM[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2376334-75-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-125879. | |
| DS18561882 | DS18561882 is a highly potent, isozyme-selective methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) inhibitor with an IC50 value of 0.0063 μM. DS18561882 also has inhibitory effect on MTHFD1 (IC50=0.57 μM). DS18561882 exhibits a good oral pharmacokinetic profile[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2227149-22-4. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-130251. | |
| DS-1971a | DS-1971a is a potent, selective, and orally active NaV1.7 inhibitor, with IC50s of 22.8 and 59.4 nM for hNaV1.7 and mNaV1.7, respectively. DS-1971a exerts analgesic effects[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1450595-86-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-131182. | |
| DS2 | DS2. Group: Biochemicals. Grades: Purified. CAS No. 374084-31-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| DS21150768 | DS21150768 is a potent, orally active HPK1 inhibitor. DS21150768 shows potent activity to enhance T-cell function. DS21150768 has anticancer effects[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3074816-62-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-157149. | |
| DS21360717 | DS21360717 is a potent and orally active FER tyrosine kinase inhibitor, with an IC50 of 0.49 nM. Anti-cancer activity[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2304654-43-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-128576. | |
| DS-3801b | DS-3801b is a potent and non-macrolide agonist of GPR38. DS-3801b is expected to be novel gastrointestinal prokinetic agents for the research of functional gastrointestinal disorders such as gastroparesis and chronic constipation[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1369412-66-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-144401. | |
| DS-437 | DS-437 is a dual PRMT5/7 inhibitor (IC50s of PRMT5/7=6 μM). DS-437 is selective for PRMT5 and PRMT7 over 29 other human protein-, DNA-, and RNA-methyltransferases. DS-437 is a S-adenosylmethionine (SAM)-competitive inhibitor of PRMT5. DS-437 also inhibits DNMT3A and DNMT3B, with IC50s of 52 and 62 μM, respectively. DS-437 inhibits the methylation of FOXP3[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1674364-87-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-124131. | |
| DS44960156 | DS44960156 is a selective MTHFD2 inhibitor with moderate to low blood-brain barrier penetration (IC50=1.6 μM, Ki=1.23 μM). DS44960156 specifically binds to the active site of MTHFD2, disrupts redox homeostasis and blocks serine-mediated one-carbon metabolism, thereby increasing the NAD+/NADH ratio and ROS levels. DS44960156 not only effectively inhibits the proliferation of glioma cells, but also enhances the sensitivity of cells to glutamine starvation-induced death. DS44960156 binds to plasma proteins, shows no mutagenicity, carcinogenicity or acute oral toxicity, and serves as a research agent for glioblastoma multiforme and other cancers[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2361327-08-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-131943. | |
| DS55980254 | DS55980254 is the orally active inhibitor for phosphatidylserine synthase 1 (PTDSS1) that blocks the synthesis of intracellular phosphatidylserine. PTDSS1 deficiency affects the balance of cell membrane phospholipid components, and activates B cell receptor (BCR) signaling pathway[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2488609-43-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-158145. | |
| DS68591889 | DS68591889 is a selective and orally active phosphatidylserine synthase 1 (PTDSS1) inhibitor. DS68591889 has no inhibitory activity against PTDSS2. DS68591889 induces the phospholipid imbalance in a wide range of cancer cells. DS68591889 negatively regulates B cell receptor (BCR)-induced Ca2+ signaling and subsequent apoptotic cell death. DS68591889 can be used for the cancer research, such as B cell lymphoma[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2488609-21-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-157562. | |
| DS69910557 | DS69910557 is a potent, selective and orally activehuman parathyroid hormone receptor 1 (hPTHR1) antagonist. DS69910557 has antagonistic activity for PTHR1 with an IC50 value of 0.08 μM. DS69910557 can be used for the research of hyperparathyroidism, hypercalcemia of malignancy and osteoporosis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3032750-17-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148350. | |
| DS89002333 | DS89002333 is an orally active and potent PRKACA inhibitor, with an IC50 of 0.3 nM. DS89002333 shows good anti-tumor activity in an FL-HCC patient-derived xenograft model (expressing the DNAJB1-PRKACA fusion gene). DS89002333 can be used in study of fibrolamellar hepatocellular carcinoma (FL-HCC)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2832159-79-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-150072. | |
| DS-9300 | DS-9300 is a potent, orally active, selective EP300/CBP HAT inhibitor with an IC50 value of 28 nM. DS-9300 has anticancer activity and can be used in prostate cancer disease research[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2259641-46-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-152241. | |
| D-Saccharic acid 1,4-lactone | D-Saccharic acid 1,4-lactone, a versatile compound extensively investigated in the field of biomedicine, holds significant therapeutic potential against various ailments like cardiovascular diseases, diabetes, and cancer. Its remarkable attributes as an antioxidant, anti-inflammatory, and anticancer agent make it an invaluable asset contributing to advancements in drug exploration and progress. Alternative Names: D-Glucaric acid, 1,4-lactone; Glucaric acid, 1,4-lactone, D-; D-Glucaric-1,4-lactone; D-Glucaro-1,4-lactone; Saccharic acid 1,4-lactone; Glucaro-1,4-lactone; Saccharo-1,4-lactone; (2S)-[(2S,3R,4R)-3,4-Dihydroxy-5-oxotetrahydro-2-furanyl](hydroxy)acetic acid. Grades: ≥95%. CAS No. 389-36-6. Molecular formula: C6H8O7. Mole weight: 192.12. | |
| D-Saccharic acid 1,4-lactone hydrate | D-Saccharic acid 1,4-lactone hydrate is an orally active β-glucuronidase inhibitor (IC50=48.4 μM). D-Saccharic acid 1,4-lactone hydrate can be used as a standard agent compared with novel β-glucuronidase inhibitors. D-Saccharic acid 1,4-lactone hydrate possesses anticarcinogenic, detoxifying, and antioxidant properties[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 61278-30-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-134453A. | |
| D(-)S-Acetyl-beta-mercapto isobutyric acid | D(-)S-Acetyl-beta-mercapto isobutyric acid. Group: Biochemicals. Alternative Names: (S) -(-)-3-(Acetylthio)isobutyric acid; (S)-(-)-3-(Acetylthio)-2-methylpropionic acid. Grades: Highly Purified. CAS No. 76497-39-7. Pack Sizes: 10g. US Biological Life Sciences. | Worldwide |
| D-(-)-Salicin | 25g Pack Size. Group: Carbohydrates, Sugars. Formula: C13H18O7. CAS No. 138-52-3. Prepack ID 11409633-25g. Molecular Weight 286.28. See USA prepack pricing. |  |
| DseD I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 10-fold overdigestion with enzyme more than 90% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 500 U; 2500U. GACNNNN↑NNGTC CTGNN↓NNNNCAG. Activity: 10000u.a./ml. Appearance: 10 X SE-buffer Y, BSA. Storage: -20°C. Form: Liquid. Source: Deinococcus species D2. Pack: 10 mM Tris-HCl (pH 7.5); 50 mM KCl; 0,1 mM EDTA; 200 μg/ml BSA; 7 mM 2-mercaptoethanol; 50% glycerol. Cat No: ET-1099RE. |  |
| D-Sedoheptulose | D-Sedoheptulose, renowned for its potential in treating an array of maladies such as cancer, diabetes, and inflammation, yields a panoply of benefits. First and foremost, this rare sugar has the capacity to thwart tumor proliferation and curtail glucose regulation. Excitingly, D-Sedoheptulose impressively re-calibrates the immune system and imbues anti-inflammatory effects. With such standout characteristics, the future may bode well for D-Sedoheptulose's prospects as a sought-after future drug. Alternative Names: D-altro-2-Heptulose; Sedoheptulose; D-altro-Heptulose; D-Altroheptulose. CAS No. 3019-74-7. Molecular formula: C7H14O7. Mole weight: 210.18. | |
| D-Sedoheptulose-7-phosphate barium salt | D-Sedoheptulose-7-phosphate barium salt is an essential biomedical agent, emerging as a pivotal catalyst across multifarious ailments. Embracing an indispensible role in the intricate orchestration of metabolic pathways and carbohydrate metabolism, its application extends to the research of enigmatic conditions like diabetes, metabolic syndrome, and glycolysis-related afflictions. Alternative Names: D-SEDOHEPTULOSE-7-PHOSPHATE BARIUM SALT; J-016442. CAS No. 17187-72-3. Molecular formula: C7H13O10PBa. Mole weight: 425.47. | |
| D-sedoheptulose 7-phosphate isomerase | In Gram-negative bacteria the enzyme is involved in biosynthesis of ADP-L-glycero-β-D-manno-heptose, which is utilized for assembly of the lipopolysaccharide inner core. In Gram-positive bacteria the enzyme is involved in biosynthesis of GDP-D-glycero-α-D-manno-heptose, which is required for assembly of S-layer glycoprotein. Group: Enzymes. Synonyms: sedoheptulose-7-phosphate isomerase; phosphoheptose isomerase; gmhA (gene name); lpcA (gene name). Enzyme Commission Number: EC 5.3.1.28. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5467; D-sedoheptulose 7-phosphate isomerase; EC 5.3.1.28; sedoheptulose-7-phosphate isomerase; phosphoheptose isomerase; gmhA (gene name); lpcA (gene name). Cat No: EXWM-5467. | |
| D-Sedoheptulose 7-phosphate lithium salt | D-Sedoheptulose 7-phosphate lithium salt is a pivotal compound assuming a paramount role in studying intricate metabolic pathways linked to malignant neoplasms and glucose mishandling disorders. Alternative Names: D-altro-Heptulose 7-phosphate lithium salt. Molecular formula: C7H15O10P.xLi. Mole weight: 290.16 (free acid basis). | |
| D-Ser11-Retatrutide | D-Ser11-Retatrutide. | |
| D-Ser(11)-Semaglutide | D-Ser(11)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Alternative Names: D-[Ser]-11-Semaglutide; (3S,9S,12S,15S,18S,21S,24S,27R,30S,33S,36S,39S,45S,48S,51S,54S,81R)-54-(((6S,12S,15S,18S,21S,24S,27S,30S,33S)-21-((1H-indol-3-yl)methyl)-1-amino-30-benzyl-27-((S)-sec-butyl)-35-carboxy-6-((carboxymethyl)carbamoyl)-12-(3-guanidinopropyl)-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazapentatriacontan-33-yl)carbamoyl)-3-(2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-2-methylpropanamido)-45-(3-amino-3-oxopropyl)-12-benzyl-39-(2-carboxyethyl)-21-(carboxymethyl)-33-(4-hydroxybenzyl)-9,15-bis((R)-1-hydroxyethyl)-18,27,30-tris(hydroxymethyl)-36-isobutyl-24-isopropyl-48,51-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,60,69,78,83-henicosaoxo-62,65,71,74-tetraoxa-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,59,68,77,82-henicosaazanonanonacontane-1,81,99-tricarboxylic acid. Grades: 95%. Molecular formula: C187H291N45O59. Mole weight: 4113.64. | |
| D-Ser(12)-Semaglutide | D-Ser(12)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Alternative Names: D-Ser-12-Semaglutide; (3S,9S,12S,15S,18S,21S,24S,27S,30R,33S,36S,39S,45S,48S,51S,54S,81R)-54-(((6S,12S,15S,18S,21S,24S,27S,30S,33S)-21-((1H-indol-3-yl)methyl)-1-amino-30-benzyl-27-((S)-sec-butyl)-35-carboxy-6-((carboxymethyl)carbamoyl)-12-(3-guanidinopropyl)-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazapentatriacontan-33-yl)carbamo. Grades: 95%. Molecular formula: C187H291N45O59. Mole weight: 4113.64. | |
| D-Ser32-Retatrutide | D-Ser32-Retatrutide. | |
| D-Ser33-Retatrutide | D-Ser33-Retatrutide. | |
| D-Ser39-Retatrutide | D-Ser39-Retatrutide. | |
| D-Ser8-Retatrutide | D-Ser8-Retatrutide. | |
| D-Ser(8)-Semaglutide | D-Ser(8)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Alternative Names: D-[Ser]-8-Semaglutide; H-His-Aib-Glu-Gly-Thr-Phe-Thr-D-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH; L-Histidyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-D-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-[N-(17-carboxy-1-oxoheptadecyl)-L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl]-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginylglycine. Grades: 95%. Molecular formula: C187H291N45O59. Mole weight: 4113.64. | |
| D-Ser(Bzl)-ol HCl | D-Ser(Bzl)-ol HCl. Alternative Names: O-Benzyl-D-serinol hydrochloride. Molecular formula: C10H15NO2·HCl. Mole weight: 217.69. | |
| D-Serinamide | D-Serinamide. CAS No. 104714-52-5. Molecular formula: C3H8N2O2. Mole weight: 104.1. | |
| D-Serinamide hydrochloride | D-Serinamide hydrochloride. Alternative Names: H-D-Ser-NH2 HCl. Grades: > 95%. CAS No. 122702-20-9. Molecular formula: C3H9ClN2O2. Mole weight: 140.57. | |
| D-Serine | A proteinogenic amino acids involved in the biosynthesis of purines and pyrimidines. Inhibitor of serine palmitoyltransferase. A neuromodulator. Group: Biochemicals. Alternative Names: (R)-2-Amino-3-hydroxypropanoic Acid; (R)-2-Amino-3-hydroxypropanoic Acid; (R)-Serine; NSC 77689. Grades: Highly Purified. CAS No. 312-84-5. Pack Sizes: 5g. US Biological Life Sciences. | Worldwide |
| D-Serine | D-Serine ((R)-Serine), an endogenous amino acid involved in glia-synapse interactions that has unique neurotransmitter characteristics, is a potent co-agonist at the NMDA glutamate receptor. D-Serinee has a cardinal modulatory role in major NMDAR-dependent processes including NMDAR-mediated neurotransmission, neurotoxicity, synaptic plasticity, and cell migration[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: (R)-Serine. CAS No. 312-84-5. Pack Sizes: 10 mM * 1 mL in Water; 500 mg; 1 g; 5 g; 10 g; 25 g; 50 g; 100 g. Product ID: HY-100808. | |
| D-Serine 1,1-Dimethylethyl Ester | D-Serine 1,1-Dimethylethyl Ester. Group: Biochemicals. Alternative Names: D-Serine tert-Butyl Ester; tert-Butyl D-Serinate. Grades: Highly Purified. CAS No. 948296-15-9. Pack Sizes: 1g. Molecular Formula: C7H15NO3, Molecular Weight: 161.199999999999. US Biological Life Sciences. | Worldwide |
| D-Serine, 99+% | Loss on Drying: Group: Biochemicals. Alternative Names: ß-Hydroxyalanine. Grades: Highly Purified. CAS No. 312-84-5. Pack Sizes: 25g. US Biological Life Sciences. | Worldwide |
| D-serine ammonia-lyase | A pyridoxal-phosphate protein. The enzyme cleaves a carbon-oxygen bond, releasing a water molecule (hence the enzyme's original classification as EC 4.2.1.14, D-serine dehydratase) and an unstable enamine product that tautomerizes to an imine form, which undergoes a hydrolytic deamination to form pyruvate and ammonia. The latter reaction, which can occur spontaneously, can also be catalysed by EC 3.5.99.10, 2-iminobutanoate/2-iminopropanoate deaminase. Also acts, slowly, on D-threonine. Group: Enzymes. Synonyms: D-hydroxyaminoacid dehydratase; D-serine dehydrase; D-hydroxy amino acid dehydratase; D-serine hydrolase; D-serine dehydratase (deaminating); D-serine deaminase; D-serine hydro-lyase (deaminating). Enzyme Commission Number: EC 4.3.1.18. CAS No. 9015-88-7. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5278; D-serine ammonia-lyase; EC 4.3.1.18; 9015-88-7; D-hydroxyaminoacid dehydratase; D-serine dehydrase; D-hydroxy amino acid dehydratase; D-serine hydrolase; D-serine dehydratase (deaminating); D-serine deaminase; D-serine hydro-lyase (deaminating). Cat No: EXWM-5278. | |
Our database is helping our users find suppliers everyday.
